FDA unveils guidance for ‘plug and play’ gene therapies
The plan builds on recent FDA moves to speed "personalized" treatments by offering an approval framework for therapies benefiting different subsets of patients with the same disease.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.